SF3783

Purpose

The bill changes the legal definition of compounding in Minnesota law by removing flavoring agents from being counted as compounding. It also creates a specific definition for a flavoring agent. The change is intended to clarify when adding flavorings to drugs is allowed and not treated as compounding, while keeping existing protections for safe preparation of medications.

Main Provisions

• Amends Minnesota Statutes 2024 section 151.01 subd. 35 (the compounding definition):
  • Compounding remains the preparation, mixing, assembling, packaging, and labeling of a drug for an identified individual patient per a prescription drug order.
  • Anticipatory compounding remains allowed.
  • It includes the preparation of drugs where all bulk drug substances and components are nonprescription.
  • It clarifies that mixing or reconstituting a drug according to labeling or manufacturer directions is not considered compounding if the labeling is approved by the FDA or the manufacturer is licensed.
  • It notes that compounding is not for research, teaching, or chemical analysis if the drug is not prepared for dispensing or administration to patients.
  • All compounding must be done pursuant to a prescription drug order unless otherwise allowed by law or board rules.
  • Minor deviations from directions (related to radioactivity, volume, or stability) that are necessary to accommodate circumstances (e.g., rate of radioactive decay or distance from the patient) are not considered compounding when done under the supervision of a licensed nuclear pharmacist or physician.
  • Explicitly states that the use of a flavoring agent to flavor a drug is not considered compounding.
• Adds Minnesota Statutes 2024 section with a new Subd. 44 Flavoring agent:
  • Defines a flavoring agent as a therapeutically inert, nonallergenic substance consisting of inactive ingredients added to a drug to improve its taste and palatability.

Significant Changes to Existing Law

• Introduces a new defined term: Flavoring agent (therapeutically inert, nonallergenic, added to improve taste/palate).
• Explicitly excludes flavoring agents from the scope of compounding, clarifying that adding flavorings does not count as compounding under the statute.
• Maintains the core framework that compounding is prescription-based and subject to FDA-approved labeling or licensed manufacturer standards, with limited exceptions for minor deviations and certain professional oversight.

Relevant terms - Compounding - Flavoring agent - Therapeutically inert - Nonallergenic - Prescription drug order - FDA (Food and Drug Administration) - Manufacturer’s directions - Anticipatory compounding - Identified individual patient - Minnesota Statutes 2024 section 151.01 - Subd. 35 - Subd. 44 - Flavoring to improve taste and palatability - Licensed nuclear pharmacist - Minor deviations (radioactivity, volume, stability)